Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes

This study describes the construction of soluble major histocompatibility complexes consisting of the mouse class I molecule, H-2Db, chemically biotinylated β2 microglobulin and a peptide epitope derived from the glycoprotein (GP; amino acids 33–41) of lymphocytic choriomeningitis virus (LCMV). Tetrameric class I complexes, which were produced by mixing the class I complexes with phycoerythrin-labeled neutravidin, permitted direct analysis of virus-specific cytotoxic T lymphocytes (CTLs) by flow cytometry. This technique was validated by (a) staining CD8+ cells in the spleens of transgenic mice that express a T cell receptor (TCR) specific for H-2Db in association with peptide GP33–41, and (b) by staining virus-specific CTLs in the cerebrospinal fluid of C57BL/6 (B6) mice that had been infected intracranially with LCMV-DOCILE. Staining of spleen cells isolated from B6 mice revealed that up to 40% of CD8+ T cells were GP33 tetramer+ during the initial phase of LCMV infection. In contrast, GP33 tetramers did not stain CD8+ T cells isolated from the spleens of B6 mice that had been infected 2 mo previously with LCMV above the background levels found in naive mice. The fate of virus-specific CTLs was analyzed during the acute phase of infection in mice challenged both intracranially and intravenously with a high or low dose of LCMV-DOCILE. The results of the study show that the outcome of infection by LCMV is determined by antigen load alone. Furthermore, the data indicate that deletion of virus-specific CTLs in the presence of excessive antigen is preceded by TCR downregulation and is dependent upon perforin

Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation.

Eosinophils are predominantly known for their contribution to allergy. Here, we have examined the function and regulation of gastrointestinal eosinophils in the steady-state and during infection with or We find that eosinophils are recruited to sites of infection, directly encounter live bacteria, and activate a signature transcriptional program; this applies also to human gastrointestinal eosinophils in humanized mice. The genetic or anti-IL-5-mediated depletion of eosinophils results in improved control of the infection, increased inflammation, and more pronounced Th1 responses. Eosinophils control Th1 responses via the IFN-γ-dependent up-regulation of PD-L1. Furthermore, we find that the conditional loss of IFN-γR in eosinophils phenocopies the effects of eosinophil depletion. Eosinophils further possess bactericidal properties that require their degranulation and the deployment of extracellular traps. Our results highlight two novel functions of this elusive cell type and link it to gastrointestinal homeostasis and anti-bacterial defense

Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its ‘Minimal Information for Studies of Extracellular Vesicles’, which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Minimal Information for Studies of Extracellular Vesicles (MISEV2023): From Basic to Advanced Approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its \u27Minimal Information for Studies of Extracellular Vesicles\u27, which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its ‘Minimal Information for Studies of Extracellular Vesicles’, which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly

Exploiting the Intergenerational Immunomodulatory Properties of Helicobacter Pylori for the Treatment of Allergic Disorders

Helicobacter pylori is a Gram-negative, helical-shaped, flagellated and microaerophilic bacterium colonizing the human stomach of about 50 % of the world's population. During several thousand years of co-existence with humans, H. pylori has acquired abilities that allow it to evade and hijack both innate and adaptive branches of the immune system in order to persist in its host. Recently, we and others have shed light on the beneficial allergy-preventing potential of this bacterium, which is rather infamous for its pathogenic role in promoting gastritis, gastric ulcers and eventually gastric cancer. Epidemiological data showed the putative protective effects of H. pylori infection on the course of immunological diseases, including asthma, other allergic diseases, and inflammatory bowel disease (IBD). Moreover, we confirmed that in murine experimental models, H. pylori infection prevents the development of atopic asthma and IBD. Interestingly, tolerizing vaccination with H. pylori-extract, VacA or GGT, which both are immunomodulators of H. pylori, is as efficient as live infection in preventing asthma and IBD. The protective effects are particularly evident in mice infected or treated at an early age, and depend on H. pylori-mediated induction of regulatory T cells (Tregs) with highly suppressive activity as well as on IL-10 produced by specific dendritic cell (DC) subsets that are controlled by the transcription factor BATF3. Herein, I aimed to further develop and extend these findings by using a more robust and translatable house dust mite-induced murine asthma model and by investigating the effects of maternal pre- and postnatal H. pylori exposure and its implication on asthma outcome in the murine offspring. Furthermore, I sought to assess whether food allergy, another typical TH2-dominated disease, might as well be prevented by neonatal H. pylori-specific interventions. Finally, we strived to identify the underlying mechanism of these potential H. pylori-dependent immunomodulations. In this work, I further extended the protective effects to a range of experimental food allergy models. I could show that neonatal infection, extract and VacA treatment prevents, although less efficient and robust than in the asthma model, food allergy development through a Treg-dependent mechanism. These treatments led to a higher frequency of Tregs as well as to an increased demethylation of the Treg-specific demethylated region (TSDR) and thus, more stable and committed Tregs. Additionally, I was able to show that prenatal and postnatal transmaternal H. pylori-treatments efficiently prevent allergic asthma development in the progeny. I characterized the associated altered immune correlates such as a decreased frequency of DCs and bulk CD4+ T cells and increased frequencies of specialized RORγt+ and CXCR3+ Treg subsets in the lungs. Furthermore, these effects were linked to shifts in the microbiota composition, as well as the epigenetic signature of Tregs (i.e. the TSDR) indicating qualitative and/or quantitative differences in the stability and functionality of Tregs. Notably, transmaternal H. pylori exposure did not lead to a generalized immunosuppression due to the fact that acute infection with influenza A virus readily broke the tolerance. Most strikingly, I was able to show that the asthma-protective effects were propagated to the second generation without any further treatments, demonstrating H. pylori's ability to beneficially impact allergy susceptibility of several generations

Altersbedingte Variationen ausgewählter Gangparameter – eine Querschnittstudie an gesunden Probanden

Hintergrund: Nach aktuellem Forschungsstand lässt sich in der Ganganalytik ein Mangel ausreichend gros-ser Normdatenbanken feststellen. Normwerte, welche gangrelevante Prädikatoren berück-sichtigen, sind notwendig, um Ganganalysen akkurat interpretieren und die Wirksamkeit von Interventionen nachweisen zu können. Das Hauptziel der Arbeit ist das Generieren von Norm-daten, welche stratifiziert nach Geschlecht in Altersgruppen dargelegt werden. Weiterführend wird untersucht, bei welchen Parametern altersbedingte Variationen und geschlechtsspezifi-sche Unterschiede festgestellt werden können. Methoden: Die Rekrutierung der im Raum Basel lebenden Probanden erfolgte zufällig, indem per Los gezogene Distrikte ausgewählt wurden. Mit dem Schweizer Ganganalysensystem, Gait Up, wurden von jedem Probanden zweiundzwanzig Gangparameter in einem Korridor mit ebener Oberfläche erhoben. Die Probanden wurden angewiesen, bei selbstgewählter Gehgeschwin-digkeit ohne Pause um eine zwanzig Meter entfernte Pylone zu gehen. Ergebnisse: Die Daten von dreihundertfünfundneunzig gesunden Probanden konnten stratifiziert nach Ge-schlecht und Altersgruppen analysiert werden. Bei zwölf der zweiundzwanzig Gangparameter konnten altersbedingte Variationen von statistischer Signifikanz nachgewiesen werden. Bei sechzehn Parametern zeigten sich statistisch signifikante Unterschiede zwischen den beiden Geschlechtern. Schlussfolgerungen: Die Arbeit generierte Referenzwerte für zweiundzwanzig Gangparameter von dreihundertfünf-undneunzig gesunden Probanden. Altersbedingte und geschlechtsabhängige Variationen wurden dargelegt. Allerdings wurden nicht alle Gangparameter durch das Alter oder Ge-schlecht beeinflusst. Im Lebensverlauf eines gesunden Menschen scheint sich beispielsweise die Gangvariabilität kaum zu verändern